The Beauty Health (SKIN) Stock: Buy, Sell, or Hold?
SKIN - The Beauty Health Company Class A Common Stock
$10.88
-0.21 (-1.94%)
βΌ
5d:
+3.03%
30d:
+1548.48%
90d:
+1354.55%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 05, 2026
12d
Get Alerted When SKIN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR BETTER ENTRY: SKIN is 34.0% above its trading range ($8.12). Market expects -23.0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
βΈοΈ WAIT FOR BETTER ENTRY: SKIN is 34.0% above its trading range ($8.12). Market expects -23.0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$46.12
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$28.64
62.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SKIN is currently trading at $10.88, which is considered extended relative to its 30-day fair value range of $-1.23 to $8.12. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.9) compared to its historical average (6.2). Remarkably, the market is currently pricing in an annual earnings decline of 23.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SKIN is in a uptrend. Immediate support is located at $0.50, while resistance sits at $12.89.
Market Sentiment: SKIN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $15.67 (+44.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SKIN is in a uptrend. Immediate support is located at $0.50, while resistance sits at $12.89.
Market Sentiment: SKIN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $15.67 (+44.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-1.23 -
$8.12
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
19.0%
All Signals
- BEARISH: Price significantly overextended (+34.0% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 44.0% below Wall St target ($15.67)
- WARNING: Composite score 31/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$-1.23 -
$8.12
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.50
Resistance Level
$12.89
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.85
Wall Street Target
$15.67
(+44.0%)
Revenue Growth (YoY)
-7.8%
Profit Margin
-9.8%
Valuation Discount vs History
-23.0% cheaper
PE vs Historical
2.9 vs 6.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-23.0%
(market-implied from PE analysis)
1-Year Target
$9.79
(-10%)
2-Year Target
$8.81
(-19%)
3-Year Target
$7.93
(-27%)
3-Yr Target (if PE normalizes)
(PE: 3β6)
$17.27
(+59%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 49.2%)
$252.07
(+2217%)
Base:
(SPY PE: 2.8, Growth: 49.2%)
$36.15
(+232%)
Bear:
(PE: 2.4, Growth: 49.2%)
$30.73
(+182%)
π‘
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.8 to 6.2
Stabilization Target:
$23.68
(+117.7%)
PE Expansion Potential:
+117.7%
Share & Embed Analysis
Last updated: October 23, 2026 5:34 PM ET
Data refreshes hourly during market hours. Next update: 6:34 PM
Data refreshes hourly during market hours. Next update: 6:34 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SKIN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Household & Personal Products Stocks
Top-rated stocks in Household & Personal Products by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EL
Estee Lauder Companies I⦠|
BUY
30 analysts |
$108 | 34 SELL |
|
PG
Procter & Gamble Company |
BUY
25 analysts |
$162 | 31 SELL |
|
CL
Colgate-Palmolive Company |
BUY
21 analysts |
$98 | 33 SELL |
|
ELF
ELF Beauty Inc |
BUY
18 analysts |
$109 | 35 SELL |
|
CHD
Church & Dwight Company β¦ |
HOLD
21 analysts |
$105 | 33 SELL |